This inventor holds 2 USPTO granted patents. Top assignee: Astrazeneca Ab. Active years: 2009-2011.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2009-2011
Title: Karen Anderson: Innovator in Anti-Thrombotic Therapy
Introduction
Karen Anderson is a prominent inventor based in Victoria, Australia. She has made significant contributions to the field of medical research, particularly in the development of anti-thrombotic therapies. With a total of 2 patents, her work focuses on innovative solutions that address critical health issues.
Latest Patents
Anderson's latest patents involve the inhibition of phosphoinositide 3-kinase β. The present invention relates to selective inhibitors of phosphoinositide (PI) 3-kinase β, which are utilized in anti-thrombotic therapy. This invention also includes a method for screening compounds that are useful for new anti-thrombotic therapy by detecting the selective inhibitory activity of PI 3-kinase β of the compound. Additionally, the invention encompasses novel compounds that act as inhibitors of PI 3-kinase.
Career Highlights
Karen Anderson is currently associated with AstraZeneca AB, where she continues to advance her research and development efforts. Her work has been instrumental in paving the way for new therapeutic options in the medical field.
Collaborations
Some of her notable coworkers include Vijaya Kenche and Shaun P Jackson, who contribute to her innovative projects and research initiatives.
Conclusion
Karen Anderson's contributions to the field of anti-thrombotic therapy highlight her role as a leading inventor in medical research. Her innovative patents and collaborations reflect her commitment to improving health outcomes through scientific advancements.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile